Loading publications…
The last 5 uploaded publications
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries
Alexander T. Cohen, Ulrich Hoffmann, Pierre Hainaut, Seán Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jiménez, Bernd Brüggenjürgen, Pierre Lévy, Petra Laeis, Eva‐Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Marius Constantin Manu, Paul‐Egbert Reimitz, Peter Bramlage, Giancarlo Agnelli (2020). ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries. , 82, DOI: https://doi.org/10.1016/j.ejim.2020.08.014.
Article76 days agoETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months
Marius Constantin Manu, Paul‐Egbert Reimitz, Peter Bramlage, Alexander T. Cohen, Giancarlo Agnelli, Ulrich Hoffmann, Pierre Hainaut, Seán Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jiménez, Bernd Brüggenjürgen, Pierre Lévy, Petra Laeis, Eva‐Maria Fronk, Wolfgang Zierhut, Thomas Malzer (2020). ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. , 196, DOI: https://doi.org/10.1016/j.thromres.2020.09.001.
Article76 days agoThe global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design
Raffaele De Caterina, Giancarlo Agnelli, Petra Laeis, Martin Unverdorben, Heiko Rauer, Chun‐Chieh Wang, Mashio Nakamura, Kuan‐Ming Chiu, Paul‐Egbert Reimitz, Yukihiro Koretsune, Cathy Chen, Ulrike Thee, Jumpei Kaburagi, Young‐Hoon Kim, Jae Hwa Cho, Takeshi Yamashita, Alexander T. Cohen, Paulus Kirchhof (2019). The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design. , 42(12), DOI: https://doi.org/10.1002/clc.23279.
Article76 days ago